✓Tender information last checkedLast checked 8 Oct 2026, 20:01.
Opportunity overview
This is a Provider Selection Regime (PSR) intention to award notice. Provision of Pathology testing services
Classification
CPV85111800 — Pathology services
Lots
Content of notice of intention to award to the existing provider under Direct Award Process C<br/><br/>1. A statement that the relevant authority is intending to award a contract to an existing provider following Direct Award Process C.<br/><br/>This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act 2023 do not apply to this award. The publication of this notice marks the start of the standstill period. Representations by providers must be made to decision makers by 19/10/2026. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR<br/><br/><br/>2.The contract title and reference.<br/><br/>Title: Provision of Pathology Testing Services<br/><br/>3.The name and address of the registered office or principal place of business of the provider to whom an award is to be made.<br/><br/>HSL PATHOLOGY LLP (TRADING AS HSL - ADVANCED DIAGNOSTICS) <br/>The Halo Building, 1 Mabledon Place, London, WC1H 9AX<br/><br/>4.A description of the relevant health care services to which the contract relates, including the most relevant CPV code<br/><br/>Description – Pathology services<br/>CPV Code – 85111800– Pathology services<br/><br/>5.The approximate lifetime value of the contract.<br/><br/>£60,000 (24 months)<br/><br/><br/><br/>6.Details of the award decision-makers.<br/><br/>Key Individuals – Queen Victoria Hospital NHS Foundation Trust<br/><br/>Head of Pathology<br/><br/><br/>7.A statement explaining the award decision-makers’ reasons for selecting the chosen provider:<br/>1. Quality and Innovation – Existing supplier for pathology testing. No issues with current supply,<br/>2. Value – They have consistently over a period of time delivered a valuable service within the available budget allocation.<br/><br/><br/>8.Any declared conflicts or potential conflicts of interest.<br/><br/><br/>None declared<br/><br/>9.Information as to how any conflicts or potential conflicts of interest were managed. N/AValue not stated
Published notice details
Additional information from the published procurement release. Fields appear only when supplied by the source; check the original notice and tender documents before acting.
Content of notice of intention to award to the existing provider under Direct Award Process C<br/><br/>1. A statement that the relevant authority is intending to award a contract to an existing provider following Direct Award Process C.<br/><br/>This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act 2023 do not apply to this award. The publication of this notice marks the start of the standstill period. Representations by providers must be made to decision makers by 19/10/2026. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR<br/><br/><br/>2.The contract title and reference.<br/><br/>Title: Provision of Pathology Testing Services<br/><br/>3.The name and address of the registered office or principal place of business of the provider to whom an award is to be made.<br/><br/>HSL PATHOLOGY LLP (TRADING AS HSL - ADVANCED DIAGNOSTICS) <br/>The Halo Building, 1 Mabledon Place, London, WC1H 9AX<br/><br/>4.A description of the relevant health care services to which the contract relates, including the most relevant CPV code<br/><br/>Description – Pathology services<br/>CPV Code – 85111800– Pathology services<br/><br/>5.The approximate lifetime value of the contract.<br/><br/>£60,000 (24 months)<br/><br/><br/><br/>6.Details of the award decision-makers.<br/><br/>Key Individuals – Queen Victoria Hospital NHS Foundation Trust<br/><br/>Head of Pathology<br/><br/><br/>7.A statement explaining the award decision-makers’ reasons for selecting the chosen provider:<br/>1. Quality and Innovation – Existing supplier for pathology testing. No issues with current supply,<br/>2. Value – They have consistently over a period of time delivered a valuable service within the available budget allocation.<br/><br/><br/>8.Any declared conflicts or potential conflicts of interest.<br/><br/><br/>None declared<br/><br/>9.Information as to how any conflicts or potential conflicts of interest were managed. N/A
Buyer location · East Grinstead · UKJ2 · RH19 3DZ · United Kingdom
Delivery location · UKJ2
Notice and amendment history
1 published notice version reviewed by ProcuraAxis.
1 VERSION
1
095433-2026planning ·
PROCURAAXIS ANALYSIS
ProcuraAxis Analysis
Our approved analysis of the opportunity appears below the official tender information.
ANALYSIS PREVIEW
Opportunity intelligence at a glance
Early-stage/planned PSR intention to award for pathology testing services. Queen Victoria Hospital NHS Foundation Trust intends to directly award a 24-month, approximately £60,000 contract to its existing provider, HSL Pathology LLP (trading as HSL - Advanced Diagnostics). The notice says the standstill period starts on publication and providers may make representations by 19/10/2026; it does not state that open bidding is available.
Who this may suit
Low for new suppliers: this is an intended Direct Award Process C award to an identified existing provider rather than an open competition.
Key points identified
Service requirementProvision of pathology testing/pathology servicesEvidence: Title: “Provision of Pathology Testing Services”; lot description: “Description – Pathology services”.
Supplier requirementsUnknownEvidence: No technical, financial, insurance, staffing, certification or accreditation requirements are stated.
Intended providerHSL Pathology LLP (trading as HSL - Advanced Diagnostics)Evidence: The notice identifies “HSL PATHOLOGY LLP (TRADING AS HSL - ADVANCED DIAGNOSTICS)” as the provider to whom an award is to be made.
97% approved-analysis confidence4 supplier criteria identified4 risks or unknowns
ProcuraAxis structures information found in published procurement records, checks the result for consistency and publishes only approved analysis. Confidence describes the completeness and consistency of the available source information; it is not a guarantee of eligibility or contract award.
Early-stage/planned PSR intention to award for pathology testing services. Queen Victoria Hospital NHS Foundation Trust intends to directly award a 24-month, approximately £60,000 contract to its existing provider, HSL Pathology LLP (trading as HSL - Advanced Diagnostics). The notice says the standstill period starts on publication and providers may make representations by 19/10/2026; it does not state that open bidding is available.
Who this may suit
Low for new suppliers: this is an intended Direct Award Process C award to an identified existing provider rather than an open competition.
Key deliverables
Pathology testing services
Continuation of pathology services from the existing provider
SUPPLIER REQUIREMENTS
4 criteria identified
Service requirement
99% confidence
Provision of pathology testing/pathology services
View supporting evidence
Title: “Provision of Pathology Testing Services”; lot description: “Description – Pathology services”.
Supplier requirements
98% confidence
Unknown
View supporting evidence
No technical, financial, insurance, staffing, certification or accreditation requirements are stated.
Intended provider
99% confidence
HSL Pathology LLP (trading as HSL - Advanced Diagnostics)
View supporting evidence
The notice identifies “HSL PATHOLOGY LLP (TRADING AS HSL - ADVANCED DIAGNOSTICS)” as the provider to whom an award is to be made.
New supplier eligibility
96% confidence
Unknown; the notice does not describe an open supplier-selection process
View supporting evidence
The notice states the authority intends to award to an existing provider following Direct Award Process C.
COMMERCIAL AND DELIVERY
Contract intelligence
Commercial
Approximate contract value
99% confidence
£60,000
View supporting evidence
Lot description: “£60,000 (24 months)”.
Contract duration
99% confidence
24 months
View supporting evidence
Lot description: “£60,000 (24 months)”.
Pricing/payment terms
99% confidence
Unknown
View supporting evidence
No pricing schedule or payment terms are stated.
Delivery
Delivery geography
90% confidence
UKJ2
View supporting evidence
Delivery location is listed as region “UKJ2”.
Detailed delivery model/location
98% confidence
Unknown
View supporting evidence
No service-delivery sites or operating model are stated.
PROCEDURE
How to respond
Regime
99% confidence
Health Care Services (Provider Selection Regime) Regulations 2023
View supporting evidence
The notice states that the award is subject to the Health Care Services (Provider Selection Regime) Regulations 2023.
Procedure
99% confidence
Direct Award Process C
View supporting evidence
The lot description states the authority is intending to award to an existing provider following “Direct Award Process C”.
Procurement Act applicability
99% confidence
Procurement Act 2023 does not apply
View supporting evidence
The notice states: “the provisions of the Procurement Act 2023 do not apply to this award.”
Standstill and representations
99% confidence
Standstill starts on publication; representations must be made to decision makers by 19/10/2026
View supporting evidence
The notice states: “The publication of this notice marks the start of the standstill period. Representations by providers must be made to decision makers by 19/10/2026.”
Award status
99% confidence
Contract not yet formally awarded
View supporting evidence
The notice states: “This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR”.
RISKS AND UNKNOWNS
Points requiring attention
Limited opportunity for new suppliers
99% confidence
High
View supporting evidence
The authority intends to award to a named existing provider using Direct Award Process C.
Representation deadline
99% confidence
19/10/2026
View supporting evidence
Representations by providers must be made to decision makers by 19/10/2026.
Early-stage/planned notice
98% confidence
Final contract award has not occurred and detailed contract terms are unknown
View supporting evidence
Display status is upcoming/planned; the notice says the contract has not yet formally been awarded. No detailed terms are provided.
Scope detail
97% confidence
Limited
View supporting evidence
The stated service description is limited to pathology testing/pathology services.
ProcuraAxis analysis supplements, but does not replace, the original notice and tender documents. Always verify eligibility, deadlines and commercial terms with the issuing authority.
Continue in your ProcuraAxis workspaceFree account · Full approved analysis